Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jennifer Ruth Bellon, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Freedman RA, Sedrak MS, Bellon JR, Block CC, Lin NU, King TA, Minami C, VanderWalde N, Jolly TA, Muss HB, Winer EP. Weathering the Storm: Managing Older Adults with Breast Cancer Amid COVID-19 and Beyond. J Natl Cancer Inst. 2020 May 25. PMID: 32449757.
    Citations:    
  2. Mittendorf EA, Bellon JR, King TA. Regional Nodal Management in Patients With Clinically Node-Negative Breast Cancer Undergoing Upfront Surgery. J Clin Oncol. 2020 Jul 10; 38(20):2273-2280. PMID: 32442075.
    Citations:    
  3. Ho AY, Wright JL, Blitzblau RC, Mutter RW, Duda DG, Norton L, Bardia A, Spring L, Isakoff SJ, Chen JH, Grassberger C, Bellon JR, Beriwal S, Khan AJ, Speers C, Dunn SA, Thompson A, Santa-Maria CA, Krop IE, Mittendorf E, King TA, Gupta GP. Optimizing Radiotherapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2020 May 14. PMID: 32417409.
    Citations:    
  4. Jacene HA, DiPiro PJ, Bellon J, Hu J, Cheng SC, Warren L, Schlosnagle E, Nakhlis F, Rosenbluth JM, Yeh E, Overmoyer B. Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning. Breast Cancer Res Treat. 2020 Jun; 181(2):383-390. PMID: 32318957.
    Citations:    
  5. Bradley JA, Bellon JR. Quality of Life and Limb: Reducing Lymphedema Risk After Breast Cancer Therapy. Int J Radiat Oncol Biol Phys. 2020 02 01; 106(2):225-229. PMID: 31928634.
    Citations:    
  6. Barroso-Sousa R, Krop IE, Trippa L, Tan-Wasielewski Z, Li T, Osmani W, Andrews C, Dillon D, Richardson ET, Pastorello RG, Winer EP, Mittendorf EA, Bellon JR, Schoenfeld JD, Tolaney SM. A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer. Clin Breast Cancer. 2020 Jun; 20(3):238-245. PMID: 32113750.
    Citations:    
  7. Braunstein LZ, Bellon JR. Contemporary Issues in Breast Cancer Radiotherapy. Hematol Oncol Clin North Am. 2020 02; 34(1):1-12. PMID: 31739937.
    Citations:    
  8. Weiss A, Wong S, Golshan M, Freedman RA, Metzger O, Bellon J, Mittendorf EA, King TA. Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach. Ann Surg Oncol. 2019 Dec; 26(13):4326-4336. PMID: 31562601.
    Citations:    
  9. Punglia RS, Ortiz Pimentel S, Cronin AM, Frank ES, Bellon JR, Abel GA, Uno H, Wong JS. Patient-preferred outcomes measurement after post-mastectomy radiation therapy and immediate reconstruction. Breast J. 2020 02; 26(2):319-321. PMID: 31495035.
    Citations:    
  10. Warren LEG, Chen YH, Halasz LM, Brock JE, Capuco A, Punglia RS, Wong JS, Golshan M, Bellon JR. Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ. Breast Cancer Res Treat. 2019 Dec; 178(3):607-615. PMID: 31493031.
    Citations:    
  11. Nakhlis F, Regan MM, Chun YS, Dominici LS, Caterson S, Bellon JR, Warren L, Yeh ED, Jacene HA, King TA, Overmoyer B. Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience. Breast J. 2020 Mar; 26(3):384-390. PMID: 31448540.
    Citations:    
  12. Grebneva Y, Bellon JR, Herderich MJ, Rauhut D, Stoll M, Hixson JL. Understanding Yeast Impact on 1,1,6-Trimethyl-1,2-dihydronaphthalene Formation in Riesling Wine through a Formation-Pathway-Informed Hydrolytic Assay. J Agric Food Chem. 2019 Dec 11; 67(49):13487-13495. PMID: 31347368.
    Citations:    
  13. Wright JL, Bellon JR. Defining the Optimal Schedule for External Beam Partial Breast Irradiation. Int J Radiat Oncol Biol Phys. 2019 07 15; 104(4):867-868. PMID: 31204662.
    Citations:    
  14. Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K, Shen AH, DeSantis S, Dominici L, Golshan M, Weiss A, Bellon J, Mittendorf EA, King TA. Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3502-3509. PMID: 31228134.
    Citations:    
  15. Atkins KM, Truong LT, Rawal B, Chen YH, Catalano PJ, Bellon JR, Punglia RS, Moreau JM, Capuco AT, Hergrueter CA, Chun YS, Wong JS. Effects of Postmastectomy Radiation Therapy on Immediate Tissue Expander and Acellular Dermal Matrix Reconstruction: Results of a Prospective Clinical Trial. Pract Radiat Oncol. 2019 Sep - Oct; 9(5):338-346. PMID: 31063823.
    Citations:    
  16. Bellon JR, Guo H, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis M, Wolff AC, Carey LA, Overmoyer BA, Partridge AH, Hudis CA, Krop I, Burstein HJ, Winer EP, Tolaney SM. Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial). Breast Cancer Res Treat. 2019 Jul; 176(2):303-310. PMID: 31004299.
    Citations:    
  17. Jacene HA, Youn T, DiPiro PJ, Hu J, Cheng SC, Franchetti Y, Shah H, Bellon JR, Warren L, Schlosnagle E, Nakhlis F, Rosenbluth J, Yeh E, Overmoyer B. Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade. Clin Breast Cancer. 2019 04; 19(2):146-155. PMID: 30584057.
    Citations:    Fields:    
  18. Jimenez RB, Bellon JR. Systemic Therapy with Radiation to the Chest Wall Alone. Int J Radiat Oncol Biol Phys. 2018 09 01; 102(1):13. PMID: 30102189.
    Citations:    Fields:    
  19. Bellon JR, Ford CM, Borneman AR, Chambers PJ. A Novel Approach to Isolating Improved Industrial Interspecific Wine Yeasts Using Chromosomal Mutations as Potential Markers for Increased Fitness. Front Microbiol. 2018; 9:1442. PMID: 30034376.
    Citations:    
  20. Grossmith S, Nguyen A, Hu J, Plichta JK, Nakhlis F, Cutone L, Dominici L, Golshan M, Duggan M, Carter K, Rhei E, Barbie T, Calvillo K, Nimbkar S, Bellon J, Wong J, Punglia R, Barry W, King TA. Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series. Ann Surg Oncol. 2018 Nov; 25(12):3527-3534. PMID: 29868979.
    Citations:    Fields:    
  21. Wong JS, Bellon JR. Radiation, then Rethink. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):265-266. PMID: 29726353.
    Citations:    Fields:    
  22. Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer. 2018; 9(8):1437-1447. PMID: 29721054.
    Citations:    
  23. Jagsi R, Griffith KA, Bellon JR, Woodward WA, Horton JK, Ho A, Feng FY, Speers C, Overmoyer B, Sabel M, Schott AF, Pierce L. Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study. J Clin Oncol. 2018 05 01; 36(13):1317-1322. PMID: 29558281.
    Citations:    Fields:    
  24. Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, Halberg F, Hoffman K, Horst K, Moran J, Patton C, Perlmutter J, Warren L, Whelan T, Wright JL, Jagsi R. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018 May - Jun; 8(3):145-152. PMID: 29545124.
    Citations: 4     Fields:    Translation:Humans
  25. Martin AM, Cagney DN, Catalano PJ, Warren LE, Bellon JR, Punglia RS, Claus EB, Lee EQ, Wen PY, Haas-Kogan DA, Alexander BM, Lin NU, Aizer AA. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study. JAMA Oncol. 2017 Aug 01; 3(8):1069-1077. PMID: 28301662.
    Citations: 11     Fields:    Translation:Humans
  26. Bellon JR. Regional Nodal Irradiation in the Anti-HER2 Era. J Natl Cancer Inst. 2017 08 01; 109(8). PMID: 28376194.
    Citations:    Fields:    
  27. Nakhlis F, Regan MM, Warren LE, Bellon JR, Hirshfield-Bartek J, Duggan MM, Dominici LS, Golshan M, Jacene HA, Yeh ED, Mullaney EE, Overmoyer B. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. 2017 Sep; 24(9):2563-2569. PMID: 28560598.
    Citations:    Fields:    Translation:Humans
  28. Mihalcik SA, Rawal B, Braunstein LZ, Capuco A, Wong JS, Punglia RS, Bellon JR, Harris JR. The Impact of Reexcision and Residual Disease on Local Recurrence Following Breast-Conserving Therapy. Ann Surg Oncol. 2017 Jul; 24(7):1868-1873. PMID: 28138856.
    Citations: 1     Fields:    Translation:Humans
  29. Dominici LS, Morrow M, Mittendorf E, Bellon J, King TA. Trends and controversies in multidisciplinary care of the patient with breast cancer. Curr Probl Surg. 2016 Dec; 53(12):559-595. PMID: 28160790.
    Citations:    Fields:    Translation:Humans
  30. Braunstein LZ, Taghian AG, Niemierko A, Salama L, Capuco A, Bellon JR, Wong JS, Punglia RS, MacDonald SM, Harris JR. Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy. Breast Cancer Res Treat. 2017 01; 161(1):173-179. PMID: 27807809.
    Citations: 5     Fields:    Translation:Humans
  31. Warren LE, Ligibel JA, Chen YH, Truong L, Catalano PJ, Bellon JR. Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer. Ann Surg Oncol. 2016 11; 23(12):3870-3879. PMID: 27448118.
    Citations: 2     Fields:    Translation:Humans
  32. Caragacianu DL, Mayer EL, Chun YS, Caterson S, Bellon JR, Wong JS, Troyan S, Rhei E, Dominici LS, Economy KE, Tung NM, Schapira L, Partridge A, Calvillo KZ. Immediate breast reconstruction following mastectomy in pregnant women with breast cancer. J Surg Oncol. 2016 Aug; 114(2):140-3. PMID: 27392534.
    Citations: 1     Fields:    Translation:Humans
  33. Wong JS, Warren LE, Bellon JR. Management of the Regional Lymph Nodes in Early-Stage Breast Cancer. Semin Radiat Oncol. 2016 Jan; 26(1):37-44. PMID: 26617208.
    Citations:    Fields:    Translation:Humans
  34. Bellon JR. Reply to A. Fiorentino et al. J Clin Oncol. 2015 Dec 20; 33(36):4314. PMID: 26527783.
    Citations:    Fields:    Translation:Humans
  35. Tanguturi SK, Bellon JR. Hypofractionation for Early-Stage Breast Cancer: No More Excuses. JAMA Oncol. 2015 Oct; 1(7):941-2. PMID: 26247338.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  36. Wright J, Bellon JR. Should Response to Preoperative Therapy Guide Local Management in Node-Positive Breast Cancer? Oncology (Williston Park). 2015 Sep; 29(9):667-8. PMID: 26384803.
    Citations:    Fields:    Translation:Humans
  37. Tanguturi SK, Lyatskaya Y, Chen Y, Catalano PJ, Chen MH, Yeo WP, Marques A, Truong L, Yeh M, Orlina L, Wong JS, Punglia RS, Bellon JR. Prospective assessment of deep inspiration breath-hold using 3-dimensional surface tracking for irradiation of left-sided breast cancer. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):358-65. PMID: 26231594.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  38. Bellon JR, Golshan M, Solin LJ. Controversies in Radiation Oncology for Early-Stage Breast Cancer. Ann Surg Oncol. 2015 Oct; 22(10):3213-8. PMID: 26202560.
    Citations:    Fields:    Translation:Humans
  39. Bellon JR, Yang F, Day MP, Inglis DL, Chambers PJ. Designing and creating Saccharomyces interspecific hybrids for improved, industry relevant, phenotypes. Appl Microbiol Biotechnol. 2015 Oct; 99(20):8597-609. PMID: 26099331.
    Citations: 4     Fields:    Translation:AnimalsCellsPHPublic Health
  40. Bellon JR. Personalized Radiation Oncology for Breast Cancer: The New Frontier. J Clin Oncol. 2015 Jun 20; 33(18):1998-2000. PMID: 25964251.
    Citations:    
  41. Warren LE, Guo H, Regan MM, Nakhlis F, Yeh ED, Jacene HA, Hirshfield-Bartek J, Overmoyer BA, Bellon JR. Inflammatory breast cancer and development of brain metastases: risk factors and outcomes. Breast Cancer Res Treat. 2015 May; 151(1):225-32. PMID: 25893587.
    Citations: 3     Fields:    Translation:Humans
  42. Warren LE, Guo H, Regan MM, Nakhlis F, Yeh ED, Jacene HA, Hirshfield-Bartek J, Overmoyer BA, Bellon JR. Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management. Ann Surg Oncol. 2015 Aug; 22(8):2483-91. PMID: 25791789.
    Citations: 2     Fields:    Translation:Humans
  43. Horton JK, Bellon JR. Oncology scan--quality of life and patient perspectives during breast radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Feb 01; 91(2):249-51. PMID: 25636750.
    Citations:    Fields:    
  44. Braunstein LZ, Niemierko A, Shenouda MN, Truong L, Sadek BT, Abi Raad R, Wong JS, Punglia RS, Taghian AG, Bellon JR. Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype. Breast J. 2015 Mar-Apr; 21(2):161-7. PMID: 25559656.
    Citations: 9     Fields:    Translation:Humans
  45. Warren LE, Punglia RS, Wong JS, Bellon JR. Management of the regional lymph nodes following breast-conservation therapy for early-stage breast cancer: an evolving paradigm. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):772-7. PMID: 25585780.
    Citations: 2     Fields:    Translation:Humans
  46. Sikov WM, Berry DA, Perou CM, Singh B, Cirrincione CT, Tolaney SM, Kuzma CS, Pluard TJ, Somlo G, Port ER, Golshan M, Bellon JR, Collyar D, Hahn OM, Carey LA, Hudis CA, Winer EP. Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance). J Clin Oncol. 2015 Jan 01; 33(1):13-21. PMID: 25092775.
    Citations: 116     Fields:    Translation:HumansCTClinical Trials
  47. Mak KS, Chen YH, Catalano PJ, Punglia RS, Wong JS, Truong L, Bellon JR. Dosimetric Inhomogeneity Predicts for Long-Term Breast Pain After Breast-Conserving Therapy. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):1087-95. PMID: 25084611.
    Citations: 5     Fields:    Translation:Humans
  48. Cifter G, Chin J, Cifter F, Sinha N, Bellon J, Sajo E, Ngwa W. WE-G-BRE-09: Targeted Radiotherapy Enhancement During Accelerated Partial Breast Irradiation (ABPI) Using Controlled Release of Gold Nanoparticles (GNPs). Med Phys. 2014 Jun; 41(6):519. PMID: 28036641.
    Citations:    
  49. Halyard MY, Harris EE, Bailey L, Bellon JR, Freedman GM, Goyal S, Horst KC, Moran MS, Park CC, Suh WW, Toppmeyer D, Haffty BG. ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer. Oncology (Williston Park). 2014 Feb; 28(2):157-64, C3. PMID: 24701707.
    Citations: 1     Fields:    Translation:Humans
  50. Tolaney SM, Jeong J, Guo H, Brock J, Morganstern D, Come SE, Golshan M, Bellon J, Winer EP, Krop IE. A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer. Cancer Med. 2014 Apr; 3(2):293-9. PMID: 24464780.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  51. Bellon JR. Oncology scan--improving our understanding of the local management of breast cancer. Int J Radiat Oncol Biol Phys. 2013 Nov 15; 87(4):627-9. PMID: 24139691.
    Citations:    Fields:    
  52. Lin NU, Freedman RA, Ramakrishna N, Younger J, Storniolo AM, Bellon JR, Come SE, Gelman RS, Harris GJ, Henderson MA, Macdonald SM, Mahadevan A, Eisenberg E, Ligibel JA, Mayer EL, Moy B, Eichler AF, Winer EP. A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases. Breast Cancer Res Treat. 2013 Nov; 142(2):405-14. PMID: 24197661.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  53. Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC. Reply to P.G. Tsoutsou et al, o. Kaidar-Person et al, and A. Courdi et al. J Clin Oncol. 2013 Dec 20; 31(36):4571-3. PMID: 24190113.
    Citations:    Fields:    Translation:Humans
  54. Yeh ED, Jacene HA, Bellon JR, Nakhlis F, Birdwell RL, Georgian-Smith D, Giess CS, Hirshfield-Bartek J, Overmoyer B, Van den Abbeele AD. What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach. Radiographics. 2013 Nov-Dec; 33(7):2003-17. PMID: 24224593.
    Citations: 3     Fields:    Translation:Humans
  55. Russo AL, Arvold ND, Niemierko A, Wong N, Wong JS, Bellon JR, Punglia RS, Golshan M, Troyan SL, Brock JE, Harris JR. Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat. 2013 Jul; 140(2):353-61. PMID: 23836011.
    Citations: 11     Fields:    Translation:Humans
  56. Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013 Jul 01; 31(19):2382-7. PMID: 23690420.
    Citations: 100     Fields:    Translation:Humans
  57. Bellon JR, Schmid F, Capone DL, Dunn BL, Chambers PJ. Introducing a new breed of wine yeast: interspecific hybridisation between a commercial Saccharomyces cerevisiae wine yeast and Saccharomyces mikatae. PLoS One. 2013; 8(4):e62053. PMID: 23614011.
    Citations: 12     Fields:    Translation:AnimalsCells
  58. Krishnan MS, Recht A, Bellon JR, Punglia RS. Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011. Breast Cancer Res Treat. 2013 Feb; 138(1):205-13. PMID: 23338762.
    Citations:    Fields:    Translation:Humans
  59. Bellon JR, Wong JS, Burstein HJ. Should response to preoperative chemotherapy affect radiotherapy recommendations after mastectomy for stage II breast cancer? J Clin Oncol. 2012 Nov 10; 30(32):3916-20. PMID: 23032626.
    Citations: 4     Fields:    Translation:Humans
  60. Recht A, Bellon JR, Punglia RS. Trade-offs associated with axillary lymph node dissection: Implications of the eligibility versus enrollment in ACOSOG Z0011. J Clin Oncol. 2012 Sep 20; 30(27_suppl):151. PMID: 28146767.
    Citations:    
  61. Childs SK, Chen YH, Duggan MM, Golshan M, Pochebit S, Punglia RS, Wong JS, Bellon JR. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):948-52. PMID: 22975615.
    Citations: 8     Fields:    Translation:Humans
  62. Callegari S, Gregory PA, Sykes MJ, Bellon J, Andrews S, McKinnon RA, de Barros Lopes MA. Polymorphisms in the mitochondrial ribosome recycling factor EF-G2mt/MEF2 compromise cell respiratory function and increase atorvastatin toxicity. PLoS Genet. 2012; 8(6):e1002755. PMID: 22719265.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  63. Ng SK, Zygmanski P, Jeung A, Mostafavi H, Hesser J, Bellon JR, Wong JS, Lyatskaya Y. Optimal parameters for clinical implementation of breast cancer patient setup using Varian DTS software. J Appl Clin Med Phys. 2012 May 10; 13(3):3752. PMID: 22584175.
    Citations: 2     Fields:    Translation:Humans
  64. Childs SK, Chen YH, Duggan MM, Golshan M, Pochebit S, Wong JS, Bellon JR. Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1133-8. PMID: 22543200.
    Citations: 1     Fields:    Translation:Humans
  65. Bizaj E, Cordente AG, Bellon JR, Raspor P, Curtin CD, Pretorius IS. A breeding strategy to harness flavor diversity of Saccharomyces interspecific hybrids and minimize hydrogen sulfide production. FEMS Yeast Res. 2012 Jun; 12(4):456-65. PMID: 22385988.
    Citations: 5     Fields:    Translation:Animals
  66. Halyard MY, Wasif N, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Horst KC, Moran MS, MacDonald SM, Haffty BG. ACR Appropriateness Criteria® local-regional recurrence (LR) and salvage surgery: breast cancer. Am J Clin Oncol. 2012 Apr; 35(2):178-82. PMID: 22433995.
    Citations: 2     Fields:    Translation:Humans
  67. Ng SK, Lyatskaya Y, Stsepankou D, Hesser J, Bellon JR, Wong JS, Zygmanski P. Automation of clip localization in Digital Tomosynthesis for setup of breast cancer patients. Phys Med. 2013 Jan; 29(1):75-82. PMID: 22206908.
    Citations:    Fields:    
  68. Halasz LM, Sreedhara M, Chen YH, Bellon JR, Punglia RS, Wong JS, Harris JR, Brock JE. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):e581-6. PMID: 22208975.
    Citations: 6     Fields:    Translation:Humans
  69. Moran MS, Bai HX, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, MacDonald SM, Haffty BG. ACR appropriateness criteria(®) ductal carcinoma in situ. Breast J. 2012 Jan-Feb; 18(1):8-15. PMID: 22107336.
    Citations: 7     Fields:    Translation:Humans
  70. Barkley C, Burstein H, Smith B, Bellon J, Wong J, Gadd M, Taghian A, Winer E, Iglehart JD, Harris J, Golshan M. Can axillary node dissection be omitted in a subset of patients with low local and regional failure rates? Breast J. 2012 Jan-Feb; 18(1):23-7. PMID: 22017599.
    Citations: 3     Fields:    Translation:Humans
  71. Childs SK, Chen Y, Pochebit S, Golshan M, Duggan MM, Wong JS, Harris JR, Bellon JR. Surgical margins and the risk of local-regional recurrence (LRR) following mastectomy for early-stage breast cancer. J Clin Oncol. 2011 Sep 20; 29(27_suppl):95. PMID: 27957926.
    Citations:    
  72. Macdonald SM, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, Haffty BG. ACR appropriateness criteria® locally advanced breast cancer. Breast J. 2011 Nov-Dec; 17(6):579-85. PMID: 21906206.
    Citations: 4     Fields:    Translation:Humans
  73. Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, Bellon JR, Wong JS, Smith BL, Harris JR. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011 Oct 10; 29(29):3885-91. PMID: 21900114.
    Citations: 71     Fields:    Translation:Humans
  74. Bellon JR, Harris EE, Arthur DW, Bailey L, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, MacDonald SM, Haffty BG. ACR Appropriateness Criteria® conservative surgery and radiation--stage I and II breast carcinoma: expert panel on radiation oncology: breast. Breast J. 2011 Sep-Oct; 17(5):448-55. PMID: 21790842.
    Citations: 7     Fields:    Translation:Humans
  75. Hattangadi-Gluth JA, Wo JY, Nguyen PL, Abi Raad RF, Sreedhara M, Niemierko A, Freer PE, Georgian-Smith D, Bellon JR, Wong JS, Smith BL, Harris JR, Taghian AG. Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1185-91. PMID: 21601377.
    Citations: 12     Fields:    Translation:Humans
  76. Blessing M, Bhagwat MS, Lyatskaya Y, Bellon JR, Hesser J, Zygmanski P. Kilovoltage beam model for flat panel imaging system with bow-tie filter for scatter prediction and correction. Phys Med. 2012 Apr; 28(2):134-43. PMID: 21570884.
    Citations: 2     Fields:    
  77. Bellon JR, Eglinton JM, Siebert TE, Pollnitz AP, Rose L, de Barros Lopes M, Chambers PJ. Newly generated interspecific wine yeast hybrids introduce flavour and aroma diversity to wines. Appl Microbiol Biotechnol. 2011 Aug; 91(3):603-12. PMID: 21538112.
    Citations: 15     Fields:    Translation:AnimalsCells
  78. Ueltzhöffer S, Zygmanski P, Hesser J, Högele W, Wong J, Bellon JR, Lyatskaya Y. Clinical application of varian OBI CBCT system and dose reduction techniques in breast cancer patients setup. Med Phys. 2010 Jun; 37(6):2985-98. PMID: 20632611.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  79. Ueltzhöffer S, Zygmanski P, Hesser J, Högele W, Wong J, Bellon JR, Lyatskaya Y. Clinical application of Varian OBI CBCT system and dose reduction techniques in breast cancer patients setup. Med Phys. 2010 Jun; 37(6Part1):2985-2998. PMID: 28512980.
    Citations:    
  80. Ahmed HM, Dipiro PJ, Devlin PM, Nguyen ML, Bellon JR. Mammographic appearance following accelerated partial breast irradiation by using MammoSite brachytherapy. Radiology. 2010 May; 255(2):362-8. PMID: 20332376.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  81. Wo JY, Taghian AG, Nguyen PL, Raad RA, Sreedhara M, Bellon JR, Wong JS, Gadd MA, Smith BL, Harris JR. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):188-96. PMID: 20171798.
    Citations: 12     Fields:    Translation:Humans
  82. Lyatskaya Y, Buehler A, Ng SK, Wong J, Bellon JR, Zygmanski P. Optimal gantry angles and field sizes in kilovoltage cone-beam tomosynthesis for set-up of women with breast cancer undergoing radiotherapy treatment. Radiother Oncol. 2009 Dec; 93(3):633-8. PMID: 19923026.
    Citations: 4     Fields:    Translation:Humans
  83. Gradishar WJ, Bellon JR, Gadd MA, D'Alessandro HA, Braaten K. Case records of the Massachusetts General Hospital. Case 30-2008. A 47-year-old woman with a mass in the breast and a solitary lesion in the spine. N Engl J Med. 2008 Sep 25; 359(13):1382-91. PMID: 18815400.
    Citations:    Fields:    Translation:Humans
  84. Javid SH, Smith BL, Mayer E, Bellon J, Murphy CD, Lipsitz S, Golshan M. Tubular carcinoma of the breast: results of a large contemporary series. Am J Surg. 2009 May; 197(5):674-7. PMID: 18789411.
    Citations: 4     Fields:    Translation:Humans
  85. Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR. Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review. J Clin Oncol. 2008 Oct 20; 26(30):4981-9. PMID: 18711171.
    Citations: 34     Fields:    Translation:Humans
  86. Partridge A, Winer JP, Golshan M, Bellon JR, Blood E, Dees EC, Sampson E, Emmons KM, Winer E. Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ. Clin Breast Cancer. 2008 Jun; 8(3):275-80. PMID: 18650159.
    Citations: 8     Fields:    Translation:Humans
  87. Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, Kelada A, Rizk L, Wong JS, Bellon JR, Gadd M, Specht M, Taghian AG. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol. 2008 May 01; 26(13):2093-8. PMID: 18445838.
    Citations: 27     Fields:    Translation:Humans
  88. Wong JS, Taghian AG, Bellon JR, Keshaviah A, Smith BL, Winer EP, Silver B, Harris JR. Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial. Int J Radiat Oncol Biol Phys. 2008 Nov 01; 72(3):866-70. PMID: 18394815.
    Citations: 2     Fields:    Translation:Humans
  89. Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008 May 10; 26(14):2373-8. PMID: 18413639.
    Citations: 186     Fields:    Translation:Humans
  90. Segara D, Krop IE, Garber JE, Winer E, Harris L, Bellon JR, Birdwell R, Lester S, Lipsitz S, Iglehart JD, Golshan M. Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol. 2007 Nov 01; 96(6):474-80. PMID: 17640031.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  91. Sher DJ, Wittenberg E, Taghian AG, Bellon JR, Punglia RS. Partial breast irradiation versus whole breast radiotherapy for early-stage breast cancer: a decision analysis. Int J Radiat Oncol Biol Phys. 2008 Feb 01; 70(2):469-76. PMID: 17967514.
    Citations: 2     Fields:    Translation:Humans
  92. Landis DM, Luo W, Song J, Bellon JR, Punglia RS, Wong JS, Killoran JH, Gelman R, Harris JR. Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys. 2007 Apr 01; 67(5):1299-308. PMID: 17275202.
    Citations: 24     Fields:    Translation:Humans
  93. Curtin CD, Bellon JR, Henschke PA, Godden PW, de Barros Lopes MA. Genetic diversity of Dekkera bruxellensis yeasts isolated from Australian wineries. FEMS Yeast Res. 2007 May; 7(3):471-81. PMID: 17233769.
    Citations: 10     Fields:    Translation:Animals
  94. Cozzolino D, Flood L, Bellon J, Gishen M, De Barros Lopes M. Combining near infrared spectroscopy and multivariate analysis as a tool to differentiate different strains of Saccharomyces cerevisiae: a metabolomic study. Yeast. 2006 Oct-Nov; 23(14-15):1089-96. PMID: 17083133.
    Citations:    Fields:    Translation:Animals
  95. Lim M, Bellon JR, Gelman R, Silver B, Recht A, Schnitt SJ, Harris JR. A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1149-54. PMID: 16750330.
    Citations: 4     Fields:    Translation:Humans
  96. Bellon JR, Katz A, Taghian A. Radiation therapy for breast cancer. Hematol Oncol Clin North Am. 2006 Apr; 20(2):239-57, vii. PMID: 16730294.
    Citations:    Fields:    Translation:Humans
  97. Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, Wong J, Gelman R, Bunnell CA, Parker LM, Garber JE, Winer EP, Harris JR, Powell SN. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer. Int J Radiat Oncol Biol Phys. 2006 Feb 01; 64(2):496-504. PMID: 16243442.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  98. Bellon JR, Harris JR. What extent of radiation therapy is standard? Breast. 2005 Dec; 14(6):532-40. PMID: 16236515.
    Citations:    Fields:    Translation:Humans
  99. Bellon JR, Come SE, Gelman RS, Henderson IC, Shulman LN, Silver BJ, Harris JR, Recht A. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol. 2005 Mar 20; 23(9):1934-40. PMID: 15774786.
    Citations: 19     Fields:    Translation:HumansCTClinical Trials
  100. Galper S, Blood E, Gelman R, Abner A, Recht A, Kohli A, Wong JS, Smith D, Bellon J, Connolly J, Schnitt S, Winer E, Silver B, Harris JR. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2005 Feb 01; 61(2):348-57. PMID: 15667952.
    Citations: 12     Fields:    Translation:Humans
  101. Stewart AJ, O'Farrell DA, Bellon JR, Hansen JL, Duggan C, Czerminska MA, Cormack RA, Devlin PM. CT computer-optimized high-dose-rate brachytherapy with surface applicator technique for scar boost radiation after breast reconstruction surgery. Brachytherapy. 2005; 4(3):224-9. PMID: 16182223.
    Citations: 2     Fields:    Translation:Humans
  102. Bellon JR, Harris JR. Chemotherapy and radiation therapy for breast cancer: what is the optimal sequence? J Clin Oncol. 2005 Jan 01; 23(1):5-7. PMID: 15545662.
    Citations: 5     Fields:    Translation:Humans
  103. Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol. 2004 Sep 01; 22(17):3608-17. PMID: 15337811.
    Citations: 181     Fields:    Translation:Humans
  104. Bellon JR, Livingston RB, Eubank WB, Gralow JR, Ellis GK, Dunnwald LK, Mankoff DA. Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC). Am J Clin Oncol. 2004 Aug; 27(4):407-10. PMID: 15289736.
    Citations: 19     Fields:    Translation:Humans
  105. Bellon JR, Shulman LN, Come SE, Li X, Gelman RS, Silver BJ, Harris JR, Recht A. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma. Cancer. 2004 Apr 01; 100(7):1358-64. PMID: 15042668.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  106. Gécz J, Shaw MA, Bellon JR, de Barros Lopes M. Human wild-type SEDL protein functionally complements yeast Trs20p but some naturally occurring SEDL mutants do not. Gene. 2003 Nov 27; 320:137-44. PMID: 14597397.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  107. de Barros Lopes M, Bellon JR, Shirley NJ, Ganter PF. Evidence for multiple interspecific hybridization in Saccharomyces sensu stricto species. FEMS Yeast Res. 2002 Jan; 1(4):323-31. PMID: 12702336.
    Citations: 26     Fields:    Translation:Animals
  108. Schwartz DL, Einck J, Bellon J, Laramore GE. Fast neutron radiotherapy for soft tissue and cartilaginous sarcomas at high risk for local recurrence. Int J Radiat Oncol Biol Phys. 2001 Jun 01; 50(2):449-56. PMID: 11380233.
    Citations: 9     Fields:    Translation:Humans
  109. Mankoff DA, Bellon JR. Positron-emission tomographic imaging of cancer: glucose metabolism and beyond. Semin Radiat Oncol. 2001 Jan; 11(1):16-27. PMID: 11146039.
    Citations: 7     Fields:    Translation:HumansAnimals
  110. Bellon JR, Lindsley KL, Ellis GK, Gralow JR, Livingston RB, Austin Seymour MM. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. Int J Radiat Oncol Biol Phys. 2000 Sep 01; 48(2):393-7. PMID: 10974452.
    Citations: 7     Fields:    Translation:Humans
  111. Bellon J, Wallner K, Ellis W, Russell K, Cavanagh W, Blasko J. Use of pelvic CT scanning to evaluate pubic arch interference of transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1999 Feb 01; 43(3):579-81. PMID: 10078640.
    Citations: 7     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Bellon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (304)
Explore
_
Co-Authors (104)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.